Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer
Status:
Recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
This study is a prospective, single-center, open-label, umbrella-shaped phase II clinical
study for patients with HR+/HER2- endocrine-resistant advanced breast cancer.